| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.2 |